These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585 [TBL] [Abstract][Full Text] [Related]
26. Strategies to help a smoker who is struggling to quit. Rigotti NA JAMA; 2012 Oct; 308(15):1573-80. PubMed ID: 23073954 [TBL] [Abstract][Full Text] [Related]
27. Tobacco quitline outcomes by service type. Kerkvliet JL; Fahrenwald NL S D Med; 2014 Jan; 67(1):25-9. PubMed ID: 24601063 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Roberts E; Eden Evins A; McNeill A; Robson D Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837 [TBL] [Abstract][Full Text] [Related]
29. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study. Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235 [TBL] [Abstract][Full Text] [Related]
30. A comparison of three smokeless tobacco dependence measures. Ebbert JO; Severson HH; Danaher BG; Schroeder DR; Glover ED Addict Behav; 2012 Nov; 37(11):1271-7. PubMed ID: 22762958 [TBL] [Abstract][Full Text] [Related]
31. A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. Ebbert JO; Croghan IT; Severson HH; Schroeder DR; Hays JT Nicotine Tob Res; 2011 Sep; 13(9):820-6. PubMed ID: 21504885 [TBL] [Abstract][Full Text] [Related]
33. Nicotine lozenges and behavioural interventions may help smokeless tobacco users to quit. Hurst D Evid Based Dent; 2015 Dec; 16(4):104-5. PubMed ID: 26680516 [TBL] [Abstract][Full Text] [Related]
34. Smoking cessation interventions for smokers with current or past depression. van der Meer RM; Willemsen MC; Smit F; Cuijpers P Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776 [TBL] [Abstract][Full Text] [Related]
35. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Stead LF; Koilpillai P; Lancaster T Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723 [TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. Le Houezec J; Aubin HJ Expert Opin Pharmacother; 2013 Oct; 14(14):1959-67. PubMed ID: 23978314 [TBL] [Abstract][Full Text] [Related]
38. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Stead LF; Lancaster T Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680 [TBL] [Abstract][Full Text] [Related]
39. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586 [TBL] [Abstract][Full Text] [Related]